NVS : Summary for Novartis AG Common Stock - Yahoo Finance

Canadian Markets closed

Novartis AG (NVS)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
71.89-0.10 (-0.14%)
At close: 4:02PM EST

71.89 0.00 (0.00%)
After hours: 4:36PM EST

People also watch
GSKSNYAZNLLYABT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close71.99
Open71.83
Bid0.00 x
Ask0.00 x
Day's Range71.70 - 72.08
52 Week Range66.93 - 83.58
Volume2,626,718
Avg. Volume3,367,801
Market Cap171.76B
Beta0.73
PE Ratio (TTM)25.35
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.72 (3.78%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com1 hour ago

    Mallinkrodt Reaches $100 Million Settlement with FTC

    Drugmaker faced antitrust charges over 2013 Synacthen deal.

  • MarketWatch10 hours ago

    Novartis CEO Discusses Impact of Trump on Drug Industry

    Novartis CEO Joseph Jimenez spoke to WSJ's Deborah Ball about the impact that a Trump presidency could have on the pharmaceutical industry.

  • Reuters13 hours ago

    Trump tax cuts could mean more Novartis investment in U.S

    Donald Trump's plans to cut U.S. corporate tax rates could trigger increased investment in the United States by Novartis, its chief executive told Reuters, despite the president-elect's recent harsh words on drug prices. "When we build a new manufacturing site we think about the tax rate, we think about the economy of the country, we think about jobs, so a booming U.S. economy would make the U.S. more attractive for investment," Joe Jimenez said on Wednesday. Trump unnerved drug company executives last week by saying the industry was "getting away with murder" on pricing and promising to introduce more competition to drive down costs.